Skip to content
Back
Most recent
Treatment non-adherence concern
Up to a quarter of anti-VEGF patients being treated for AMD and diabetic macular oedema are lost to follow-up.
Retinal implant trial
An electronic retinal implant to treat age-related macular degeneration, has shown excellent results in a small clinical trial.
New WA Research Centre for Juvenile Macular Disease
MDFA Research Grant recipient Dr Fred Chen will head a new Centre of Research Excellence in juvenile macular disease.
New sight saving resources for residential aged care
A report and new digital training tools aim to improve understanding of eye health and vision loss in Australia’s residential aged care facilities.
PBS listing a “big win” says MDFA
A change to the Pharmaceutical Benefits Scheme listing for two key medicines, is a “big win for the macular disease community”.
MDFA position statement re 2RT laser.
MDFA position statement re 2RT laser.
Depression, suicide and AMD
The impact of vision loss due to AMD on patients’ quality of life and psychological well-being is comparable to that of cancer or coronary heart disease.
Val Nicholson: Prioritising AMD treatment
After the initial shock of diagnosis, Val realised she needed to accept that age-related macular degeneration is part of her life.
Government announces National Action Plan funding
The federal today announced funding for MDFA to develop a Strategic National Action Plan for Macular Disease.